Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

A new therapeutic strategy for atypical HUS

Joel L. Moake

Blood (2017) 130 (3): 243–244.

https://doi.org/10.1182/blood-2017-06-783704

Published: 2017

Journal Articles

Acquired von Willebrand syndrome associated with left ventricular assist device

Angelo Nascimbene, Sriram Neelamegham, O. H. Frazier, Joel L. Moake, Jing-fei Dong

Blood (2016) 127 (25): 3133–3141.

https://doi.org/10.1182/blood-2015-10-636480

Published: 2016

Journal Articles

Factor H (FH) Is Released Slowly and Continuously from Human Endothelial Cells (ECs): FH Is Not Packaged in Weibel-Palade Bodies or Secreted in Response to EC Stimulation

Sarah E Sartain, MD, Nancy A Turner, BS, Hui Shiu-Ki, MD, Charles G. Minard, PhD, Joel L Moake, MD

Blood (2014) 124 (21): 4175.

https://doi.org/10.1182/blood.V124.21.4175.4175

Published: 2014

Journal Articles

Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage

Nancy A. Turner, Leticia Nolasco, Zaverio M. Ruggeri, Joel L. Moake

Blood (2009) 114 (24): 5102–5111.

https://doi.org/10.1182/blood-2009-07-231597

Published: 2009

Journal Articles

ADAMTS-13 Has a Disulfide Bond Reduction Activity on Von Willebrand Factor

Zhou Zhou, Hiuwan Choi, Zhenyin Tao, Khatira Aboulfatova, Leticia Nolasco, Joel L. Moake, MD, Jing-fei Dong, MD, PhD

Blood (2008) 112 (11): 3934.

https://doi.org/10.1182/blood.V112.11.3934.3934

Published: 2008

Journal Articles

Factor H Binds to Von Willebrand Factor (VWF) and Regulates Its Cleavage by ADAMTS-13

Miguel A. Cruz, PhD, Francisca C. Gushiken, MD, Rolando Rumbaut, Kavita N Patel, Nancy Turner, Leticia Nolasco, Hyojeong Han, Matthew Pickering, Jing-fei Dong, MD, PhD, Joel L. Moake, MD, Vahid Afshar-Kharghan, MD

Blood (2008) 112 (11): 3935.

https://doi.org/10.1182/blood.V112.11.3935.3935

Published: 2008

Journal Articles

Thermodynamic Analysis of Von Willebrand Disease Type 2B and 2M Mutations on the Structural Stability of the Von Willebrand Factor A1 Domain.

Matthew Auton, BSc, PhD, Erik Sedlák, PhD, Joel L. Moake, MD, Miguel A. Cruz, PhD

Blood (2008) 112 (11): 3389.

https://doi.org/10.1182/blood.V112.11.3389.3389

Published: 2008

Journal Articles

Protein Phosphatase 2B Inhibition Promotes the Secretion of Von Willebrand Factor from Endothelial Cells

Leticia Nolasco, Francisca C. Gushiken, MD, Vimal Patel, BS, Nancy Turner, Subhashree Pradhan, Ph.D., Jing-fei Dong, MD, PhD, Joel L. Moake, MD, K. Vinod Vijayan, PhD

Blood (2008) 112 (11): 692.

https://doi.org/10.1182/blood.V112.11.692.692

Published: 2008

Journal Articles

Ticlopidine- and Clopidogrel-Associated Thrombotic Thrombocytopenic Purpura (TTP): Final Results from the Surveillance Epidemiology and Risk Factor-TTP Study Group.

Elizabeth A. Richey, BA, Charles L. Bennett, MD, PhD, MPP, Hau C. Kwaan, MD, PhD, Anaadriana Zakarija, MD, MSCI, Nicholas Banderanko, MD, Dilip K. Pandey, MD, PhD, June M. McKoy, MD, JD, MPH, Paul R. Yarnold, PhD, Dennis W. Raisch, PhD, Jeffrey L. Winters, MD, Thomas J. Raife, MD, John F. Cursio, MS, Matthew J. Fisher, Thomas L. Ortel, MD, PhD, Martin S. Tallman, MD, Masanori Matsumoto, MD, PhD, Yoshihiro Fujimura, MD, PhD, Joel L. Moake, MD

Blood (2007) 110 (11): 2089.

https://doi.org/10.1182/blood.V110.11.2089.2089

Published: 2007

Journal Articles

Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWF strings by ADAMTS13 under flow conditions

Zhenyin Tao, Yuandong Peng, Leticia Nolasco, Santiago Cal, Carlos Lopez-Otin, Renhao Li, Joel L. Moake, José A. López, Jing-fei Dong

Blood (2005) 106 (13): 4139–4145.

https://doi.org/10.1182/blood-2005-05-2029

Published: 2005

Journal Articles

Hemolytic uremic syndrome–associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers

Leticia H. Nolasco, Nancy A. Turner, Aubrey Bernardo, Zhenyin Tao, Thomas G. Cleary, Jing-fei Dong, Joel L. Moake

Blood (2005) 106 (13): 4199–4209.

https://doi.org/10.1182/blood-2005-05-2111

Published: 2005

Journal Articles

P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface

Arnoldo Padilla, Joel L. Moake, Aubrey Bernardo, Chalmette Ball, Yongtao Wang, Maneesh Arya, Leticia Nolasco, Nancy Turner, Michael C. Berndt, Bahman Anvari, José A. López, Jing-Fei Dong

Blood (2004) 103 (6): 2150–2156.

https://doi.org/10.1182/blood-2003-08-2956

Published: 2004

Journal Articles

ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions

Jing-fei Dong, Joel L. Moake, Leticia Nolasco, Aubrey Bernardo, Wendy Arceneaux, Corie N. Shrimpton, Alicia J. Schade, Larry V. McIntire, Kazuo Fujikawa, José A. López

Blood (2002) 100 (12): 4033–4039.

https://doi.org/10.1182/blood-2002-05-1401

Published: 2002

Journal Articles

Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers

Maneesh Arya, Bahman Anvari, Gabriel M. Romo, Miguel A. Cruz, Jing-Fei Dong, Larry V. McIntire, Joel L. Moake, JoséA. López

Blood (2002) 99 (11): 3971–3977.

https://doi.org/10.1182/blood-2001-11-0060

Published: 2002

Journal Articles

Blockade of adenosine diphosphate receptors P2Y 12 and P2Y 1 is required to inhibit platelet aggregation in whole blood under flow

Nancy A. Turner, Joel L. Moake, Larry V. McIntire

Blood (2001) 98 (12): 3340–3345.

https://doi.org/10.1182/blood.V98.12.3340

Published: 2001

NARROW

A new therapeutic strategy for atypical HUS

Acquired von Willebrand syndrome associated with left ventricular assist device

Factor H (FH) Is Released Slowly and Continuously from Human Endothelial Cells (ECs): FH Is Not Packaged in Weibel-Palade Bodies or Secreted in Response to EC Stimulation

Endothelial cell ADAMTS-13 and VWF: production, release, and VWF string cleavage

ADAMTS-13 Has a Disulfide Bond Reduction Activity on Von Willebrand Factor

Factor H Binds to Von Willebrand Factor (VWF) and Regulates Its Cleavage by ADAMTS-13

Thermodynamic Analysis of Von Willebrand Disease Type 2B and 2M Mutations on the Structural Stability of the Von Willebrand Factor A1 Domain.

Protein Phosphatase 2B Inhibition Promotes the Secretion of Von Willebrand Factor from Endothelial Cells

Ticlopidine- and Clopidogrel-Associated Thrombotic Thrombocytopenic Purpura (TTP): Final Results from the Surveillance Epidemiology and Risk Factor-TTP Study Group.

Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWF strings by ADAMTS13 under flow conditions

Hemolytic uremic syndrome–associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers

P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface

ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions

Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers

Blockade of adenosine diphosphate receptors P2Y 12 and P2Y 1 is required to inhibit platelet aggregation in whole blood under flow

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only